These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1030142)

  • 41. Behaviour of myocardial contractility during the course of an acute infarction. Influence of coronary drugs.
    Cardioli E; Mantovani BA; D'Elia N; Martinelli M
    Arzneimittelforschung; 1977 Jul; 27(7):1493-8. PubMed ID: 578481
    [No Abstract]   [Full Text] [Related]  

  • 42. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of beta 1-adrenostimulants in circulatory failure in patients with chronic inflammatory lung diseases].
    Gavrisiuk VK; Morskaia ND; Iachnik AI; Morozova NA; Iakhnitsia TV
    Kardiologiia; 1990 Mar; 30(3):32-5. PubMed ID: 2199719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral oxyfedrine on left ventricular performance in patients of ischaemic heart disease.
    Puri VK; Mehrotra A; Agarwal SK; Hasan M
    J Assoc Physicians India; 1985 Apr; 33(4):269-71. PubMed ID: 4030673
    [No Abstract]   [Full Text] [Related]  

  • 45. [Regional myocardial circulation, regional blood flow distribution and ventricular wall function with oxyphedrin in a poststenotic ischemic myocardial region].
    Simon H; Felix R; Neumann G; Hedde J; Schaede A; Thurn P; Winkler C
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():289. PubMed ID: 613619
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effects of oxyfedrine on haemodynamics in patients with acute myocardial infarction (author's transl)].
    Rettig G; Sternitzke N; Hufnagl HD; Fröhlig G; Schieffer H; Bette L
    Dtsch Med Wochenschr; 1978 Mar; 103(13):445-60. PubMed ID: 639680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ageusia as the aftereffect of oxyfedrine use].
    Lantzsch W; Fikentscher R; Obrebowski A
    Otolaryngol Pol; 1991; 45(2):148-50. PubMed ID: 2067860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dextran-intolerance (author's transl)].
    Misgeld V; Mende C
    Med Klin; 1974 Sep; 69(36):1452-5. PubMed ID: 4140461
    [No Abstract]   [Full Text] [Related]  

  • 49. Observations with Mydocalm in angiological practice.
    Balogh A
    Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of oxyfedrine on the atrioventricular condutionn system studied using the bundle-of-His electrogram].
    Barbosa J; Lopes AS; Lopes JS; Benchimol CB; Ginefra P; Benchimol AB
    Arq Bras Cardiol; 1976 Aug; 29(4):331-5. PubMed ID: 1008725
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of nonachlazine and oxyfedrine on central processes regulating vasomotor tone].
    Darinskiĭ NV
    Biull Eksp Biol Med; 1980 Jul; 89(7):45-9. PubMed ID: 7407370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bronchial obturation by broncholiths as a cause of recurrent bronchopulmonary inflammatory processes and late recognition of the basic disease].
    Brikmanis EP; Freĭnate AA; Zaleskiĭ RR
    Ter Arkh; 1987; 59(3):95-7. PubMed ID: 3603400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

  • 54. [Changes of plasma renin activity during perfusion with dextran 40. Functional study; statistical evaluations and cl-nical considerations].
    Solitro A; Volpe R; Vaccaro E; Lionetti L; Lucantoni A; Torcia L
    Arch Sci Med (Torino); 1979; 136(1):117-34. PubMed ID: 464788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of intravenous oxyfedrine on exercise in patients with ischaemic heart disease.
    Alexander T; Krishnaswami S
    Indian Heart J; 1991; 43(1):21-4. PubMed ID: 1894296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Suppression of myocardial lipid peroxidation during preventive treatment of transitory coronary insufficiency with myophedrine].
    Litvitskiĭ PF; Kogan AKh; Kudrin AN; Luk'ianova LO; Ol'binskaia LI
    Farmakol Toksikol; 1981; 44(3):303-7. PubMed ID: 7286187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intra-arterial treatment of arterial obliterative disease (author's transl)].
    Mörl H
    Dtsch Med Wochenschr; 1974 Nov; 99(45):2284-6. PubMed ID: 4448136
    [No Abstract]   [Full Text] [Related]  

  • 59. Excretion of norephedrine by man after oral administration of oxyfedrine.
    Appel E; Planz G; Palm D; Grobecker H; Stratmann D; Donike M
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):161-6. PubMed ID: 1233214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.